CAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
This is to inform mentioned share certificates has been reported as lost by the shareholders of the company.19-09-2023
19-09-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of 6000 securities pursuant to ESOP15-09-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation under Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding one-on-one meeting with Analysts/Institutional Investors13-09-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
This is to inform that mentioned share certificate has been reported as lost by the shareholder.09-09-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
This is to inform that mentioned share certificate has been reported as lost by the shareholder of the company07-09-2023
Caplin Point shares hit 52-week high after US FDA's EIR to its subsidiary
The rally came a day after a subsidiary of the Chennai-based pharmaceutical company received an establishment inspection report for one of its units05-09-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
We wish to inform you that pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the schedule of one-on-one meeting of Analysts/ Institutional Investors with the Company representatives in Physical meeting will be held on September 7th, 2023 at 10:30 AM05-09-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
We wish to inform you that pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the schedule of one-on-one meeting of Analysts/ Institutional Investors with the Company representatives in Virtual meeting will be held on September 7th, 2023 at 4 PM05-09-2023
Caplin receives USFDA's voluntary action indicated status; shares down
The inspection took place from May 22nd to May 31st, and the inspection classification by the agency was determined as Voluntary Action Indicated (VAI)04-09-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release regarding our Subsidiary Caplin Steriles Limited.04-09-2023